1. Home
  2. MKSI vs RGEN Comparison

MKSI vs RGEN Comparison

Compare MKSI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MKS Instruments Inc.

MKSI

MKS Instruments Inc.

HOLD

Current Price

$155.50

Market Cap

11.0B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$157.57

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MKSI
RGEN
Founded
1961
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
8.2B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
MKSI
RGEN
Price
$155.50
$157.57
Analyst Decision
Buy
Buy
Analyst Count
11
10
Target Price
$149.36
$170.90
AVG Volume (30 Days)
847.9K
696.6K
Earning Date
11-05-2025
10-28-2025
Dividend Yield
0.56%
N/A
EPS Growth
820.97
N/A
EPS
4.12
0.03
Revenue
$3,832,000,000.00
$707,890,000.00
Revenue This Year
$10.71
$17.84
Revenue Next Year
$7.30
$12.57
P/E Ratio
$37.83
$6,185.26
Revenue Growth
8.13
11.74
52 Week Low
$54.84
$102.97
52 Week High
$170.37
$182.52

Technical Indicators

Market Signals
Indicator
MKSI
RGEN
Relative Strength Index (RSI) 51.35 47.50
Support Level $162.65 $160.11
Resistance Level $170.37 $165.02
Average True Range (ATR) 5.84 4.97
MACD -0.04 -1.27
Stochastic Oscillator 43.61 7.12

Price Performance

Historical Comparison
MKSI
RGEN

About MKSI MKS Instruments Inc.

MKS Inc formerly, MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others, used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: